NFE2L2 and cancer: Additionally, aberrant activation of NRF2 in cancer cells also occurs through alternative mechanisms, including the oncogene-induced transcription of NRF2 via KRAS, BRAF, MYC activation [14,15] or epigenetic silencing of KEAP1 [16,17].